Summary
42 human intracranial tumours were investigated by the leucocyte migration inhibition technique at various antigen concentrations with and without autologous serum addition. A correlation was found between migration rate and antigen concentration. Autologous serum addition resulted in a non-specific stimulation of migration, however, stimulation by immune complexes was also present. Migration stimulation, as an in-vitro-equivalent of immunologic tumour enhancement, is discussed.
Similar content being viewed by others
References
Akiyoshi, T., Hata, A., Tsuji, H., In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration. GANN66 (1975), 167–174.
Andersen, V., Bjerrum, O., Bendixen, G., SchiØdt, T., Dissing, I., Effect of autologous mammary tumor extracts on human leukocyte migration in vitro. Int. J. Cancer5 (1970), 357–363.
Baldwin, R. W., Embleton, M. J., Price, M. R., Robins, A., Immunity in the tumor-bearing host and its modification by serum factors. Cancer34 (1974), 1452–1460.
Bendixen, G., SØborg, M., A leukocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man. Dan. Med. Bull.16 (1969), 1–5.
Black, M. M., Leis, H. P., Shore, B., Zachran, R. E., Cellular hypersensitivity to breast cancer. Cancer33 (1974), 952–958.
Blank, I., Untersuchungen über den Einflu\ von Immunkomplexen auf die in-vitro-Migration von Blutgranulozyten des Menschen. Allergie Immunol.23 (1977), 313–321.
Böker, D.-K., über zellvermittelte Immunreaktionen bei menschlichen Hirntumoren. Neurochirurgia23 (1980), 229–234.
Brem, S. S., de Tribolet, N., Dohan, F. C., Kornblith, P. L., Demonstration of cell-mediated immunity to a human brain tumor: Use of an in vitro microcytotoxicity assay. Surg. Forum23 (1972), 428–430.
Brooks, W. H., Horwitz, D. A., Netsky, M. G., Evidence for tumor-specific immune response in patients with primary brain tumors. Surg. Forum23 (1972), 430–432.
Brostoff, J., “Escape” from leukocyte migration inhibition. J. Immunol. Methods4 (1974), 27–30.
Cerni, C., Der Migrationshemmtest. öst. Ärzteztg.32 (1977), 1200–1205.
Cochran, A. J., Mackie, R. M., Ross, C. E., Ogg, L. J., Jackson, A. M., Leukocyte migration inhibition by cancer patients' sera. Int. J. Cancer18 (1976), 274–281.
Elias, E. G., Elias, L. L., Autogenous leukocyte migration in human malignancies. Cancer36 (1975), 1393–1398.
Falk, R. E., Mann, P., Langer, B., Cell-mediated immunity to human tumors. Arch. Surg.107 (1973), 261–265.
Fritz, J., Grond, K., Der Einflu\ von autologem Serum auf den Leukozyten-Migrations-Inhibitions-Test beim Melanomalignom. Arch. Derm. Res.258 (1977), 121–126.
Gleicher, N., Beers, Ph., Cohen, C. J., Kerenyi, Th. D., Gusberg, S., Leukocyte migration enhancement as an indicator of immunologic enhancement. Amer. J. Obstet. Gynecol.136 (1980), 126–131.
Guillou, J. P., Giles, G. R., Inhibition of leukocyte migration by tumorassociated antigens of the colon and rectum. GUT (1973), 733–738.
Hellström, I., Hellström, K. E., Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms. Cancer34 (1974), 1461–1468.
Kumar, S., Taylor, G., Steward, J. K., Waghe, M. A., Morris-Jones, P., Cell-mediated immunity and blocking facotrs in patients with tumors of the central nervous system. Int. J. Cancer12 (1973), 194–205.
Levy, N. L., Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J. Immunol.21 (1978), 903–015.
McCoy, J. L., Jerome, L. F., Dean, J. H., Perlin, E., Oldham, R. K., Char, D. H., Cohen, M. H., Felix, E. L., Herberman, R. B., Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J. Natl. Cancer Inst.55 (1975), 19–23.
Nyerges, G., Nyerges, Gy, Molnar, L., Kovacs, F., Leukocyte migration inhibition by brain tissue antigens in acute inflammatory disease of the nervous system. Acta Allergol.29 (1974), 433–443.
Pees, H. W., Cytotoxic immune response of meningioma patients towards allogenic and autologous tumor cells before and after surgery. Acta neurochir. (Wien)50 (1979), 217–227.
Sheikh, K. M. A., Apuzzo, M. L. J., Weiss, M. H., Specific cellular immune responses in patients with malignant gliomas. Cancer Res.39 (1979), 1733–1738.
SØborg, M., Bendixen, G., Human leukocyte migration as a parameter of delayed hypersensitivity. Acta Med. Scand.181 (1967), 247–255.
Weisbart, R. H., Bluestone, R., Goldberg, L. S., Pearson, C. M., Migration enhancement factor: A new lymphokine. Proc. Nat. Acad. Sci. U.S.A.71 (1974), 875–879.
Wolberg, W. H., Inhibition of leukocyte migration by human tumors. Arch. Surg.109 (1974), 211–214.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Böker, D.K. Human intracranial tumours: Effect of autologous serum addition on leucocyte migration inhibition. Acta neurochir 65, 227–237 (1982). https://doi.org/10.1007/BF01405849
Issue Date:
DOI: https://doi.org/10.1007/BF01405849